Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis

J Nephrol. 2007 Mar-Apr;20(2):119-29.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic / immunology*
  • Biomarkers / metabolism*
  • Humans
  • Randomized Controlled Trials as Topic / trends
  • Recurrence
  • Vasculitis / immunology*
  • Vasculitis / metabolism*

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Biomarkers